The Global Embolization Market Is Witnessing High Growth Owing To the High Developments Done By Major Companies in the Market Worldwide
Embolization Market, by Product Type (Particles (Radioembolization Spheres, Drug-eluting Beads, Microspheres (or Blands beads, without drug), and PVA particles (Polyvinyl Alcohol), Liquid Embolic, Plugs, and Coils), by Indication (Hemorrhage/Bleeding, Benign Prostatic Hyperplasia (BPH), Uterine Fibroid, Tumor (Malignant, including Liver Cancer), Malformation (AVM, AVF), Venous embolization (incl. Varicocele forex), and Others), by End User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.
Market Overview:
Embolization is a treatment used to stop bleeding caused by abnormal blood vessels. During embolization, an interventional radiologist (an expert in using x-rays to guide a catheter) inserts a catheter into the abnormal artery or vein and injects special materials or soft metal coils that block blood flow to the vessel. The procedure is less invasive than surgery and most people experience less pain and swelling after a procedure and can return to their normal activities quickly.
The Embolization Market is predicted to reach US$ 1,433.6 million in 2020 and grow at a CAGR of 8.1% during the forecast period (2020-2027).
Competitive Landscape:
Major players operating in the global Embolization Market include Stryker Corporation, Johnson & Johnson, Medtronic, Terumo Medical Systems, Boston Medical Corporation, IMbiotechnologies Ltd., Emboline, Inc., Rapid Medical, Artio Medical Inc., Shape Memory Medical Inc., Cardiva, Meril Life Sciences Pvt. Ltd., Merit Medical Systems, Penumbra, Inc., Kaneka Corporation, Cook Medical, Balt, Acandis GmbH, Abbott Laboratories, and Sirtex Medical Limited.
Key Market Drivers:
Increasing developments by key players in the global embolization for market are expected to augment the growth of the market. For instance, in April 2021, the United States Food and Drug Administration (FDA) approved Medtronic PLC's Pipeline Flex Embolization Device with Shield Technology, for treating brain aneurysms.
Before embolization, patients will be going through an ultrasound or CT scan to see the arteries and veins in the body that are affected by the disease. Patients also are told to stop taking certain medicines, such as blood thinners, for a few days before the procedure. Moreover, the high incidence of chronic diseases such as neurovascular diseases, cardiovascular diseases, and cancer is estimated to enhance the growth of the global embolization market.
Covid-19 Impact Analysis:
During the COVID-19 pandemic, there have been several developments in the global embolization market. For instance, in July 2021, Terumo Medical Corporation launched the first and only micro catheter plug called AZUR Vascular Plug.
The global Vascular Embolization Market is anticipated to increase over the course of the projected period as vascular illnesses become more prevalent around the world.
Key Takeaways:
· North America is expected to dominate the growth of the global Embolization Market, owing to the high prevalence of key companies in the region. For instance, in March 2021, Boston Scientific received the approval of the United States Food and Drug Administration (FDA) for its TheraSphere Y-90 Glass Microspheres.
· The Asia Pacific is estimated to witness high growth in the global embolization for market, owing to the increasing rate of developments by major players in the region. For instance, in January 2021, Terumo Corporation received the approval of the U.S. Food and Drug Administration for its PMA Supplement for the WEB 17 System. This is a new addition to the company’s WEB Aneurysm Embolization System.
Comments
Post a Comment